期刊文献+

健脾益气补肾法辅助化疗治疗非小细胞肺癌临床观察 被引量:7

下载PDF
导出
摘要 目的观察健脾益气补肾法配合化疗对晚期非小细胞肺癌(NSCLC)患者临床中医证候疗效、细胞免疫功能及生存质量的影响。方法60例晚期NSCLC患者随机分为治疗组与对照组各30例,均采用DC化疗方案;治疗组辅以中药健脾益气补肾方治疗,疗程12周。结果治疗组中医证候疗效、1年生存率及患者生活质量均明显提高,无明显不良反应;治疗组治疗后CD3、CD4、CD4/CD8均较治疗前提高,与对照组治疗后比较,差异显著。结论健脾益气补肾法可明显改善NSCLC患者的生存质量。
出处 《中国中医急症》 2009年第12期1959-1960,2016,共3页 Journal of Emergency in Traditional Chinese Medicine
  • 相关文献

参考文献11

二级参考文献44

  • 1迟小伟,刘杰.胃癌患者B7-CD28共刺激通路的研究[J].临床检验杂志,2005,23(2):106-107. 被引量:6
  • 2熊丁丁,武勇琴.穿孔素介导的溶细胞作用的研究进展[J].上海免疫学杂志,1996,16(1):56-59. 被引量:7
  • 3钱书兵.肿瘤抗原研究与肿瘤免疫治疗[J].国外医学(肿瘤学分册),1996,23(6):337-340. 被引量:1
  • 4Michel F,Attal Bonnefoy G, Mangino G, et al. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity, 2001,15: 935-945.
  • 5Carreno BM, Collins M. The B7 family of ligands and its receptors:new pathways for costimulation and inhibition of immune response.Annu Rev Immunol, 2002, 20: 29-53.
  • 6Kruger K, Buning C, Schriever F. Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. Eur J Immunol, 2001, 31:138-145.
  • 7Sansom D,Manzotti C,Zheng Y.What's the difference between CD80 and CD86[J].Trends in Immunology,2003,24(6):313-318.
  • 8ShinT,Kennedy G,Gorski K,et al.Cooerative B7-1/2(CD80/CD86) and B7-DC costimulation of CD4^+ T cells independent of the PD-1 receptor[J].Journal of Experimental Medcine,2003,198(1):31-38.
  • 9Wang SD,Bajorath J,Dallas B.Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction[J].Journal of Experimental Medcine,2003,197(9):1083-1091.
  • 10Ito T,Ueno T,Clarkson MR,et al.Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo1[J].Journal of Immunology,2005,174(3):6648-6656.

共引文献879

同被引文献90

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部